drugset / Trial / NCT06816277
Application of Local Melatonin in Peri-implantitis
RandomizedParallel-groupTriple-blindTreatment
Summary
A randomized clinical trial was carried out in patients affected by peri-implantitis with a follow-up of 60 days. Melatonin 1.9 mg or placebo was applied locally to the peri-implant defect after nonsurgical debridement. To determine the effectiveness anti-inflammatory, osteogenic and antimicrobial properties were evaluated. The probing depth, bleeding index, plaque index, and interleukin-1β and 6 concentrations, peri-implant bone level and the bacterial strains were analyzed.
Timeline
- Start
- 2020-09-01
- Primary completion
- 2023-07-15
- Completion
- 2023-07-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Melatonin | Small molecule | 1.9 mg | Other |